Correlation of Serum Endothelial Dysfunction Markers with CT Angiographic Findings in Ischemic Stroke

Asian Pacific Journal of Tropical Disease

Volumn 2, Issue SUPPL.1, 2012, Pages

  Varyani, Neeraj ^a   Tripathi, Suchi ^a   Thukral, Anubhav ^a   Mishra, Manish ^b   Garg, Sunny ^a   Tripathi, Kamlakar ^a   Dwivedi, Amit Nandan D ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b St Vincent and the Grenadines West Indies ^*  (Trinidad and Tobago)

Author keywords

CT Angiography; High sensitive c reactive protein (hsCRP); Stroke; Total nitric oxide (NO) and superoxide dismutase (SOD)

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERTENSION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSIENT ISCHEMIC ATTACK;

EID: 84869001244     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(12)60115-7     Document Type: Article

References (32)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:188-197.
2. Huang PH, Kim CX, Lerman A, Cannon CP, Dai D, et al. Trends in smoking cessation counseling: experience from american heart association-get with the guidelines. Clin Cardiol 2012, 35:396-403.
3. Pereira S, Graham JR, Shahabaz A, Salter K, Foley N, et al. Rehabilitation of individuals with severe stroke: synthesis of best evidence and challenges in implementation. Top Stroke Rehabil 2012, 19:122-131.
4. Hilbrich L, Truelsen T, Yusuf S Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development. Int J Stroke 2007, 2:104-108.
5. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123.
6. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 2009, 32(Suppl 2):S314-S321.
7. Mishra M, Kumar H, Bajpai S, Singh RK, Tripathi K Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Diabetes Res Clin Pract 2011, 94:255-261.
8. Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 2009, 335:165-189.
9. Mallika V, Goswami B, Rajappa M Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 2007, 58:513-522.
10. Ghasemi A, Zahedi Asl S, Mehrabi Y, Saadat N, Azizi F Serum nitric oxide metabolite levels in a general healthy population: relation to sex and age. Life Sci 2008, 83:326-331.
11. Knauer C, Knauer K, Müller S, Ludolph AC, Bengel D, et al. A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study. BMC Neurol 2012, 8:12-14.
12. Ozkul A, Akyol A, Yenisey C, Arpaci E, Kiylioglu N, Tataroglu C Oxidative stress in acute ischemic stroke. J Clin Neurosci. 2007, 14:1062-1066.
13. Scrutinio D, Passantino A, Di Serio F, Angiletta D, Santoro D, Regina G High-sensitivity C-reactive protein predicts cardiovascular events and myocardial damage after vascular surgery. J Vasc Surg 2011, 54:474-479.
14. Everett BM, Glynn RJ, MacFadyen JG, Ridker PM Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation. 2010, 121:143-150.
15. Vijay SK, Mishra M, Kumar H, Tripathi K Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes. Acta Diabetol 2009, 46:27-33.
16. Thukral A, Mishra M, Srivastava V, Kumar H, Dwivedi AN, et al. Determinants of intravascular resistance in Indian diabetic nephropathy patients: a hospital-based study. Int J Vasc Med 2011, 2011:656030.
17. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 2003, 108:166-170.
18. Iso H, Noda H, Ikeda A, Yamagishi K, Inoue M, et al. The Impact of C-Reactive Protein on Risk of Stroke, Stroke Subtypes, and Ischemic Heart Disease in Middle-Aged Japanese: the Japan Public Health Center-Based Study. J Atheroscler Thromb 2012, 19. http://dx.doi.org/10.5551/jat.11999.
19. Oyama N, Yagita Y, Sasaki T, Omura-Matsuoka E, Terasaki Y, et al. An angiotensin II type 1 receptor blocker can preserve endothelial function and attenuate brain ischemic damage in spontaneously hypertensive rats. J Neurosci Res 2010, 88:2889-2898.
20. Kamide T, Kitao Y, Takeichi T, Okada A, Mohri H, et al. RAGE mediates vascular injury and inflammation after global cerebral ischemia. Neurochem Int 2012, 60:220-228.
21. Manso H, Krug T, Sobral J, Albergaria I, Gaspar G, et al. Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility. Atherosclerosis 2012, 220:443-448.
22. Rothwell PM, Gibson R, Warlow CP Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. On behalf of the European Carotid Surgery Trialists' Collaborative Group. Stroke 2000, 31:615-621.
23. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005, 111:2768-2775.
24. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000, 20:2094-2099.
25. Spranger M, Krempien S, Schwab S, Donneberg S, Hacke W Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Correlation with clinical course and infarct size. Stroke. 1997, 28:2425-2428.
26. Nanetti L, Raffaelli F, Vignini A, Perozzi C, Silvestrini M, et al. Oxidative stress in ischaemic stroke. Eur J Clin Invest 2011, 41:1318-1322.
27. Zimmermann C, Winnefeld K, Streck S, Roskos M, Haberl RL Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol 2004, 51:157-161.
28. Danesh J, Collins R, Appleby P, Peto R Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998, 279:1477-1482.
29. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
30. Elkind MS, Luna JM, Moon YP, Liu KM, Spitalnik SL, et al. High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Neurology 2009, 73:1300-1307.
31. Di Napoli M, Papa F Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 2003, 34:2922-2929.
32. Martinez-Gomez D, Gomez-Martinez S, Ruiz JR, Diaz LE, Ortega FB, et al. Objectively-measured and self-reported physical activity and fitness in relation to inflammatory markers in European adolescents: the HELENA Study. Atherosclerosis 2012, 221:260-267.